Quadria Capital Plans Major Exits via Maxivision and Aragen IPOs by 2027
Source: Mint Companies
Arth Insight · What this means for your wallet
- Potential for new investment opportunities in growing healthcare sectors.
- Upcoming IPOs could offer chances to buy into established companies at initial offering prices.
- Increased competition and investor interest may impact valuations of existing healthcare stocks.
Wealth-Impact Simulator
See what a one-time investment could grow to.
Indicative estimate for education only — not investment advice.
Explore investmentsHealthcare-focused private equity firm Quadria Capital is targeting 1.5x cash returns for its investors by early 2027. The firm plans to achieve this through public listings of portfolio companies like Maxivision Eye Hospital and Aragen Life Sciences.
- ▸Quadria Capital aims to return 1.5 times the invested cash to its Fund III backers by early 2027.
- ▸The exit strategy heavily relies on the upcoming IPOs of Maxivision Eye Hospital and Aragen Life Sciences.
- ▸The firm is capitalizing on high liquidity and favorable valuations in the Indian healthcare market.
- ▸Retail investors should watch for these upcoming healthcare IPOs as potential portfolio additions.
- ✓Quadria Capital aims to return 1.5 times the invested cash to its Fund III backers by early 2027.
- ✓The exit strategy heavily relies on the upcoming IPOs of Maxivision Eye Hospital and Aragen Life Sciences.
- ✓The firm is capitalizing on high liquidity and favorable valuations in the Indian healthcare market.
- ✓Retail investors should watch for these upcoming healthcare IPOs as potential portfolio additions.
Quadria Capital, a leading healthcare-focused private equity firm, has announced an aggressive exit strategy aimed at delivering significant returns to its backers. The firm is targeting a 1.5x cash return from its third fund (Fund III) by early 2027, leveraging the current high liquidity in the Indian capital markets.
IPO Pipeline: Maxivision and Aragen
The cornerstone of this exit strategy involves the public listing of two major portfolio companies: Maxivision Eye Hospital and Aragen Life Sciences. According to Amit Varma, co-founder and managing partner of Quadria Capital, these Initial Public Offerings (IPOs) are timed to tap into the strong domestic appetite for healthcare and pharmaceutical stocks.
- Maxivision Eye Hospital: A leading eye care chain in India, expected to seek a public listing to fund further expansion and provide an exit route for early investors.
- Aragen Life Sciences: A major contract research, development, and manufacturing organization (CRDMO) that serves the global pharmaceutical and biotech industries.
Strategic Shift to Cash Returns
The move signals a shift from capital deployment to capital return. While Quadria continues to scout for new opportunities in the South Asian healthcare sector, the immediate priority for Fund III is to crystallize gains. The firm believes that the Indian market's current valuation premiums for healthcare services make it an opportune time for exits.
What This Means for the Healthcare Sector
The planned IPOs of Maxivision and Aragen are expected to add significant depth to the healthcare segment of the Indian stock exchanges. For retail investors, these upcoming listings represent new opportunities to gain exposure to specialized healthcare services and pharmaceutical research sectors, which have shown resilience and growth post-pandemic.
Quadria’s confidence in achieving a 1.5x return within the next three years underscores the robust growth trajectory of private-equity-backed healthcare firms in India. As these companies transition from private to public ownership, they are likely to face increased scrutiny regarding corporate governance and long-term profitability.
This report is for informational purposes only and does not constitute financial or investment advice.
Community Pulse · This story
How readers rate the outlook after reading this article. Anonymous · one vote per reader · updates live.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.
Frequently Asked Questions
Which companies is Quadria Capital planning to list on the stock exchange?
Quadria Capital is planning public listings for Maxivision Eye Hospital and Aragen Life Sciences.
What is the timeline for Quadria Capital's planned exits?
The firm aims to complete these exits and provide returns to investors by early 2027.
Why is Quadria Capital choosing to exit now?
The firm is leveraging strong domestic market liquidity and high demand for healthcare stocks in India to maximize returns.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about Stock Market
Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth
Sakar Healthcare's share price saw a significant jump, trading at ₹817.45 today, following a 120% year-on-year rise in net profit for Q1 FY27. The stock has delivered a remarkable 350% return over the past five years.
IPOBreakingCube Highways InvIT IPO: Allotment on July 29, Check Status Online
The allotment for Cube Highways Trust InvIT IPO, which was oversubscribed 9.35 times, is scheduled for July 29. Investors can check their share allotment status on the Kfin Technologies portal.
IPOChina Stocks Rebound as Memory Chipmaker CXMT Makes Blockbuster Market Debut
Chinese equity markets recovered on Monday as the successful listing of memory chipmaker CXMT Corp boosted investor sentiment. The surge in CXMT shares helped the CSI300 and Shanghai Composite indices gain ground following recent selloffs.
Related Stories
Sakar Healthcare Stock Surges 350% in 5 Years on Strong Profit Growth
Sakar Healthcare's share price saw a significant jump, trading at ₹817.45 today, following a 120% year-on-year rise in net profit for Q1 FY27. The stock has delivered a remarkable 350% return over the past five years.
IPOBreakingCube Highways InvIT IPO: Allotment on July 29, Check Status Online
The allotment for Cube Highways Trust InvIT IPO, which was oversubscribed 9.35 times, is scheduled for July 29. Investors can check their share allotment status on the Kfin Technologies portal.
IPOChina Stocks Rebound as Memory Chipmaker CXMT Makes Blockbuster Market Debut
Chinese equity markets recovered on Monday as the successful listing of memory chipmaker CXMT Corp boosted investor sentiment. The surge in CXMT shares helped the CSI300 and Shanghai Composite indices gain ground following recent selloffs.
IPOCXMT Shares Surge 500% in Shanghai Debut After Asia’s Largest IPO
Chinese chipmaker CXMT Corp saw its stock price skyrocket by 500% on its first day of trading on the Shanghai Stock Exchange. The company’s market valuation has now reached 3.65 trillion yuan (approx. ₹42.5 lakh crore), overtaking major banks like ICBC.
